HAVN Life to Present at Upcoming LD Micro Invitational XII
HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness
HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies
HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility
7 Stocks to Buy if You Think Alternative Therapies Are the Future
HAVN Life Signs Agreement to Enable Export of Psilocybin into Canada, the US and Europe
HAVN Life Signs Exclusive Supply Agreement With Cube Psytech
HAVN Life is Looking for a Safe Haven to Mental Health Through Psychedelic Medicine
HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings
HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches
Havn Life CEO Tim Moore to Appear at Upcoming Q2 Investor SummitHavn Life CEO Tim Moore to Appear at Upcoming Q2 Investor Summit
Havn Life Signs Exclusive Supply Agreement with ATMA Journey Centers
Havn Labs Jamaica Facility Now Fully Operational
Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division
Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness
Havn Life CEO to Present at Zooming with LD, a Leading Platform for Microcap Companies